We would love to hear your thoughts about our site and services, please take our survey here.
Happy Groundhog Day ;-)
Polar reducing their holding
Silverback and Sharedealer please if you have to **** each other off do it elsewhere.
I think all of us on here are just waiting until 7:00am on Monday for that life changing RNS to drop.
It feels like just prior to P2 results - Almost like a Tsunami with the share price retreating slightly before the Tsunami which will be THAT RNS and we can all go back to worrying about how we’ll all spend our fortunes and make the world a better place…..and maybe we can all chip in for a room hire to watch you 2 slog it out :-)
Seriously peeps let’s all spend time with our families and drink - See you all on Monday.
Someone topping up before news
Southampton, UK - 6 January 2022: Synairgen plc (LSE: SNG), the respiratory company developing SNG001 (inhaled interferon-beta or IFN-beta) for the treatment of COVID-19 as potentially the first host-targeted, broad-spectrum antiviral treatment delivered directly into the lungs, today announces a partnership with global experts in strategic engagement and commercialisation, Ashfield Engage.
Leveraging its COVID-19 experience, Ashfield Engage is supporting Synairgen as it builds its commercialisation infrastructure for the needs of SNG001, initially in the US, pending completion of pivotal trials and regulatory authorisations. This will include the recruitment of dedicated medical affairs, patient services, commercial and market access teams.
SNG001 is an investigational inhaled formulation of the naturally occurring antiviral protein IFN-beta for potential use in patients hospitalised with COVID-19. The SARS-CoV-2 virus supresses local production of IFN-beta prevents induction of anti-viral responses by infected cells.
"There remains an urgent need for new therapies to treat hospitalised COVID-19 patients in order to prevent disease progression, accelerate hospital discharge and enable patients to quickly resume their usual activities," said Richard Hennings, Chief Commercial Officer of Synairgen. "We are excited to be working with Ashfield Engage given their relevant COVID-19 experience and are confident they understand our needs and values as we build the optimal team."
In November 2021, Synairgen announced that it had completed enrolment of 610 patients in its Phase 3 SPRINTER trial (SG018) and expects top-line data early this year. SNG001 has also recently graduated to the Phase 3 part of the US National Institute of Health's ACTIV-2 trial.
Greg *****, Global President of Ashfield Engage, said: "It is a privilege to support Synairgen in bringing this innovative potential treatment to COVID-19 patients. Having initially collaborated with Synairgen regarding patient support, we have together developed a truly consultative approach - taking the time to fully understand patient needs and providing solutions in both hospital and home settings.
"We're grateful that our collaboration has now evolved into a significantly wider partnership which will see us recruiting experts to support delivery of this novel nebulised antiviral to patients, providing MSLs to educate on the SNG001 treatment, and establishing medical information services to respond to patient enquiries."
SNG001 has been granted Fast Track status from the US Food and Drug Administration (FDA) and the Phase 3 SPRINTER trial was classified as an Urgent Public Health study by the UK's National Institute for Health Research (NIHR).
No financial terms have been disclosed regarding the partnership with Ashfield Engage.
So for anyone that thinks Covid is over
https://twitter.com/marklevinenyc/status/1477802021218656261?s=21
TR-1 dropped now - Polygon topping up prior to results
TR-1 dropped for Polar. Increasing
HeleB - May be an old fishwives tale but my father with chronic asthma and COPD swears by Cider Vinegar with honey. For years he was on inhalers and tablets for recurrent chest infections but since using this very rarely requires his inhalers now.
It’s worth a try if nothing else.
MM’s are desperate for shares this morning - Briefly seen 198 sell to 214 buy! Don’t get caught out by having stop losses on too close. Let this run.
Interesting to see SYGGF up nearly 14%.
For anyone that doesn’t believe how powerful and corrupt some of these Pharmas are should watch Dopesick on Disney+. Goes to show what large amounts of cash can do and they almost become untouchable.
Looking forward to next week and see where the share price goes in anticipation of P3 results and unblinding.
Nice rise and now in auction
Expecting share price to finish above £2.10 today and continue run up in price until we get THAT RNS.
Let’s get back to what this share is all about - Changing lives financially and health wise.
Let’s not worry about all the other noise.
Gla LTH and genuine SNG’rs
Mystic Meg seems to have got it wrong AJ316 -
“ Mystic megs back, called it last time bang on the money not said it since but ’ve got that feeling again. RNS inbound tomorrow morning heard it here first.”
I suppose you still have 2 hours to prove us wrong!
When you see this you know he must be right :-)
only way is down...28 Jul 2021 11:23
Looks like global covid cases are coming down. UK are leading the way with covid cases dropping daily!
Ragz your little bits of information have yet to be proved right and the above just shows how Ill informed you are.
£.1.63
Seems the Pfizer news has impacted here - Now showing in auction and sp £1.70
Certain this will be SNG soon and we can all smoke Cuban cigars and expensive Scotch
For anyone that wants to know a little more about the new appointee -
https://uk.linkedin.com/in/candiceopenshaw
From knowledge of her work she’s not there to make people redundant.